Neurogene (NGNE) Stock Price, Quote, News & History | Benzinga

SPY777.16−0.12%QQQ742.07−0.53%BTC/USD83,145.24+1.72%DIA515.84−0.40%GLD380.90−0.33%TLT78.32+0.35%

Neurogene Inc (NGNE) Stock Price, Quote, News & History

NGNENASDAQ

Trade with Public

Trade with Public

$22.39

-2.05-8.39%

Last update: Oct 13, 1:18 PM

$24.27

-0.17-0.7%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$24.33

Close

-

Volume / Avg.

134.75K / 252.61K

Day Range

$22.39 - $22.39

52 Wk Range

15.93 - 43.66

Market Cap

$489.08M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

24

Short Interest

29.5%

Days to Cover

11.73

Recent Neurogene Inc. News

Yatsen Holding, Delta Air Lines, United Airlines And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures lower, Dow futures down 1%. Yatsen Holding shares fall 10.1%, while other stocks also down in pre-market trading.

Avi Kapoor

Nasdaq Down Over 1%; Dell Shares Jump After Q4 Results

U.S. stocks down mid-trading, Nasdaq falls 1%. Dow down 1.40%, S&P 500 falls 0.74%. Dell shares up 21% on Q4 earnings.

Avi Kapoor

Autodesk, Arlo Technologies, Beyond Meat, Netflix And Other Big Stocks Moving Higher On Friday

Autodesk Inc (ADSK) rose sharply after beating Q4 earnings & issuing strong guidance. Other gainers include AAOI, NGNE, ARLO, PRAA, BYND, BWIN, PSKY, & DELL.

Avi Kapoor

Neurogene Stock Soars On FDA Breakthrough Tag For Rett Gene Therapy

Neurogene stock jumps after FDA grants Breakthrough Therapy status to NGN-401 for Rett syndrome treatment.

Vandana Singh

Why Applied Optoelectronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-86.82M

Investing Cash Flow (TTM)

103.94M

Financing Cash Flow (TTM)

36.55M

Free Cash Flow (TTM)

-87.71M

Capital Expenditure (TTM)

-890.00K

Net Change in Cash (TTM)

53.67M

Analyst Trends and Forecast

1

Jun

3

Aug

1

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$311.26M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

2.25

Earnings Yield % (TTM)

-20.62%

Earnings Yield % (FWD)

-21.13%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$10.85

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$43.00K

Total Cash

$112.49M

Debt to Equity

0.04

Issuance of Debt (TTM)

-$43.00K

Repayment of Debt (TTM)

-$43.00K